Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen – The New York Times December 29, 2022
Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials April 7, 2022April 7, 2022
Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles December 21, 2021December 21, 2021
Alzheimer’s drug Aduhelm: What one ex-FDA adviser called ‘probably the worst drug approval decision in recent US history’ September 26, 2021
Aduhelm Alzheimer’s: How everyone on Medicare could end up paying for the pricey new drug July 10, 2021July 10, 2021